These findings have revealed that the anti-inflammatory and neuroprotective mechanisms of dauricine might lead to the suppression of microglia activation via targeting the inhibition of STAT5-NF-κB in ischemic stroke. The gene discussed is NFKB1; the disease is ischemic stroke.